Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Total Non-Current Liabilities: 2011-2012

Historic Total Non-Current Liabilities for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Sep 2012 value amounting to $11.9 million.

  • Sonoma Pharmaceuticals' Total Non-Current Liabilities rose 96.42% to $11.9 million in Q3 2012 from the same period last year, while for Sep 2012 it was $11.9 million, marking a year-over-year increase of 96.42%. This contributed to the annual value of $6.7 million for FY2012, which is 7.93% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Total Non-Current Liabilities stood at $11.9 million for Q3 2012, which was up 61.79% from $7.4 million recorded in Q2 2012.
  • Sonoma Pharmaceuticals' 5-year Total Non-Current Liabilities high stood at $11.9 million for Q3 2012, and its period low was $6.1 million during Q3 2011.
  • For the 2-year period, Sonoma Pharmaceuticals' Total Non-Current Liabilities averaged around $7.5 million, with its median value being $6.8 million (2011).
  • Data for Sonoma Pharmaceuticals' Total Non-Current Liabilities shows a peak YoY surged of 96.42% (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Total Non-Current Liabilities (Quarterly) stood at $6.8 million in 2011, then surged by 96.42% to $11.9 million in 2012.
  • Its Total Non-Current Liabilities stands at $11.9 million for Q3 2012, versus $7.4 million for Q2 2012 and $6.7 million for Q1 2012.